company background image
SOT

Societe de Therapeutique Marocaine CBSE:SOT Stock Report

Last Price

د.م1.45k

Market Cap

د.م10.4b

7D

-0.3%

1Y

-3.3%

Updated

01 Dec, 2022

Data

Company Financials
SOT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

SOT Stock Overview

Societe de Therapeutique Marocaine S.A., a pharmaceutical company, manufactures and sells medicines in Morocco.

Rewards

Earnings have grown 12.6% per year over the past 5 years

Risk Analysis

No risks detected for SOT from our risk checks.

Societe de Therapeutique Marocaine S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Societe de Therapeutique Marocaine
Historical stock prices
Current Share Priceد.م1,445.00
52 Week Highد.م1,737.00
52 Week Lowد.م1,330.00
Beta-0.069
1 Month Change-3.02%
3 Month Change-3.73%
1 Year Change-3.28%
3 Year Change277.78%
5 Year Change284.05%
Change since IPO983.76%

Recent News & Updates

Recent updates

Shareholder Returns

SOTMA PharmaceuticalsMA Market
7D-0.3%-1.8%1.0%
1Y-3.3%-28.5%-17.1%

Return vs Industry: SOT exceeded the MA Pharmaceuticals industry which returned -28.5% over the past year.

Return vs Market: SOT exceeded the MA Market which returned -17.1% over the past year.

Price Volatility

Is SOT's price volatile compared to industry and market?
SOT volatility
SOT Average Weekly Movement3.5%
Pharmaceuticals Industry Average Movement4.3%
Market Average Movement4.8%
10% most volatile stocks in MA Market6.3%
10% least volatile stocks in MA Market3.1%

Stable Share Price: SOT is less volatile than 75% of MA stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: SOT's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19761,267Lamia Tazihttps://www.sothema.com

Societe de Therapeutique Marocaine S.A., a pharmaceutical company, manufactures and sells medicines in Morocco. It offers antibiotics; and allergology, oncology, cardiology, dental, dermatology, endocrinology, gastroenterology, gynecology, ophthalmology, ENT, pediatric, pulmonology, reanimation, rheumatology, CNS, and urology, as well as other generic drugs. The company offers its products in various forms, such as tablets, capsules, pouches, syrups, suspensions, powders, collyriums, suppositories, creams and pomades, injectable solutions, and self-injectable syringes.

Societe de Therapeutique Marocaine S.A. Fundamentals Summary

How do Societe de Therapeutique Marocaine's earnings and revenue compare to its market cap?
SOT fundamental statistics
Market Capد.م10.40b
Earnings (TTM)د.م306.25m
Revenue (TTM)د.م2.23b

34.0x

P/E Ratio

4.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SOT income statement (TTM)
Revenueد.م2.23b
Cost of Revenueد.م1.11b
Gross Profitد.م1.12b
Other Expensesد.م813.01m
Earningsد.م306.25m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)42.53
Gross Margin50.11%
Net Profit Margin13.71%
Debt/Equity Ratio21.3%

How did SOT perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

59%

Payout Ratio